title: Study design considerations: conducting global clinical trials in early Alzheimer's disease.
authors.affiliation: Alzheimer's Disease, Pfizer, Inc., New York, NY 10017, USA. Rachel.Schindler@Pfizer.com
authors.forename: R J
authors.initials: RJ
authors.lastname: Schindler
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics; D015415:Biomarkers; D002986:Clinical Trials as Topic / Q000191:economics / Q000331:legislation & jurisprudence / Q000379:methods*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D015195:Drug Design; D014943:Global Health; D033161:Government Regulation; D006801:Humans; D007391:International Cooperation / Q000331:legislation & jurisprudence; D012015:Reference Standards; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers